Aardvark Therapeutics, Inc. Common Stock (AARD) quarterly cash flow statement — complete operating, investing & financing history
Aardvark Therapeutics, Inc. Common Stock (AARD) cash flow statement — 4-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|
| Cash from Operations | -17.6M | -18.87M | -14.42M | -18.52M | -9.84M | -11.39M | -7.73M | -3.96M | -4.21M | -2.19M | -1.16M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -78.78% | -65.69% | -86.66% | -368.19% | -133.55% | -420% | -568.43% | - | - | - | - |
| Net Income | -14.39M | -21.59M | -17.6M | -16.32M | -14.37M | -9.31M | -8.78M | -4.18M | -5.45M | -2.18M | -2.04M |
| Depreciation & Amortization | 11K | -118K | 10K | 10K | -620K | 5K | -121K | 87K | 48K | 2K | 25K |
| Stock-Based Compensation | 1.95M | 2M | 0 | 0 | 634K | 233K | 173K | 145K | 54K | 67K | 69K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -2.34M | 110K | 3.84M | -1.21M | 124K | 41K | 185K | 91K | -41K | 238K | 97K |
| Working Capital Changes | -2.83M | 723K | -673K | -999K | 4.38M | -2.36M | 815K | -96K | 1.17M | -319K | 694K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -2.41M | 2.42M | -2.37M | -612K | 2.58M | 648K | 1.19M | -584K | 634K | -445K | 932K |
| Cash from Investing | 28.75M | 34.25M | 24.3M | 29.25M | 9.41M | -112.62M | -11.89M | -5K | -93K | -5K | 0 |
| Capital Expenditures | 0 | 0 | 0 | -4K | -91K | 0 | -6K | -5K | -93K | -5K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | -11.89M | 0 | 0 | 0 | 0 |
| Cash from Financing | 262K | 4K | -2.11M | 2.56M | -71K | 88.88M | -1.01M | 64K | 82.94M | 0 | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 262K | 4K | -2.11M | 2.56M | -71K | 88.88M | 163K | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | -1.18M | 64K | 82.94M | 0 | 0 |
| Net Change in Cash | 11.41M | 15.38M | 7.77M | 13.29M | -506K | -35.14M | -20.64M | -3.9M | 78.63M | -2.19M | -1.16M |
| Free Cash Flow | -17.6M | -18.87M | -14.42M | -18.52M | -9.94M | -11.39M | -7.73M | -3.96M | -4.31M | -2.19M | -1.16M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -77.14% | -65.69% | -86.51% | -367.7% | -130.62% | -418.82% | -568.94% | - | - | - | - |
| FCF per Share | -0.81 | -0.86 | -0.66 | -0.85 | -0.46 | -0.53 | -0.36 | -0.19 | -0.20 | -0.10 | -0.05 |
| FCF Conversion (FCF/Net Income) | 1.22x | 0.87x | 0.82x | 1.13x | 0.69x | 1.22x | 0.88x | 0.95x | 0.77x | 1.01x | 0.57x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |